Clinical Trials Logo

H. Pylori Infection clinical trials

View clinical trials related to H. Pylori Infection.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06176547 Not yet recruiting - H.Pylori Infection Clinical Trials

Relation of Helicobacter Pylori in Prediabetic Patients

Start date: March 1, 2024
Phase:
Study type: Observational

The primary objective of this study is to : find the relation between H.pylori infection and pre-diabetic patients with lipid profile . Specifically, the study aims to: 1. affect of H.pylori infection in pre-diabetic patients 2. realation between Pre-diabetic patient and lipid profile 3. Risk factor of H.pylori infection in pre-diabetic patients D)HbA1C test measures your average blood sugar level over the past 2 or 3 months. e)Fasting Blood Sugar Test. f) the IgG antibody of h.pylori.

NCT ID: NCT05951998 Not yet recruiting - H.Pylori Infection Clinical Trials

Frequency of h.Pylori in Children With Dyspeptic Symptoms

Start date: August 1, 2023
Phase:
Study type: Observational

The current work aim to: Estimation of prevalence, Estimation of risk factors, Estimation of endoscopic picture of H. pylori infection in children presented with chronic or recurrent dyspeptic symptoms and/or non variceal hematemesis.

NCT ID: NCT05882968 Not yet recruiting - H.Pylori Infection Clinical Trials

Prevalence of H.Pylori in CKD Patients

Start date: July 1, 2023
Phase:
Study type: Observational

The study aims to:- - Investigate the relationship between H. pylori and CKD, in order to determine whether an association exists between H.pylori and kidneys.

NCT ID: NCT05789550 Not yet recruiting - H Pylori Infection Clinical Trials

HELICOBACTER PYLORI INFECTION IN TYPE 2 DIABETES MELLITUS IN ASSIUT UNIVERSITY HOSPITAL

Start date: April 1, 2023
Phase:
Study type: Observational

The aim is to study the association of H. pylori infection with T2DM and its relation with glycated hemoglobin (HbA1c) levels

NCT ID: NCT05444439 Not yet recruiting - H Pylori Infection Clinical Trials

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

Start date: September 2022
Phase: N/A
Study type: Interventional

- Detection of primary antimicrobial susceptibility and resistance of Helicobacter Pylori infection. - Detection of resistance and virulence genes of Helicobacter Pylori infection. - Assessment of H pylori carcinogenicity gene. - Evaluation of outcome and efficacy of antibiotics regimen will be used in our research. - Evaluation of effect of other factors as diet (fatty and spicy meal), drugs as NSAIDs use, antibiotics for any cause on response of H pylori to antibiotics regimen.

NCT ID: NCT05387005 Not yet recruiting - H. Pylori Infection Clinical Trials

Screening Strategy for Gastric Cancer Prevention

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

There are still some unsolved questions regarding population-based screening program for H. pylori infection to prevent gastric cancer, such as how to perform the optimal screening strategies. A prospective, randomized trial will be conducted to compare the acceptability, compliance (/adherence), and accuracy of diagnostic tests in a population-based H. pylori screening and gastric cancer prevention program. The investigators will recruit 10,000 adults with age of ≥20 years who have not received H. pylori screening or treatment. Eligible patients will be randomly 1:1:1:1 allocated to four groups with different combination tests.

NCT ID: NCT04550858 Not yet recruiting - H.Pylori Infection Clinical Trials

h.Pylori Ttt With Rebamipide

Start date: September 5, 2020
Phase:
Study type: Observational

the primary aim is specially in resistant cases of H.pylori and in promotion of peptic ulcer

NCT ID: NCT03911791 Not yet recruiting - H Pylori Infection Clinical Trials

Screening of Helicobacter Pylori in Children of Positive Infected Mothers

Start date: April 1, 2020
Phase:
Study type: Observational

Helicobacter pylori is aspiral shaped gram negative organism that colonized the gastric mucosa.it was showen that intra familial infection play role in transmission of H pylori and mother play the key role in transmission .

NCT ID: NCT02761005 Not yet recruiting - H. Pylori Infection Clinical Trials

Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori

EHR
Start date: May 2016
Phase: Phase 2
Study type: Interventional

Patients infected with H. pylori are treated with the individualized regimen which is based on the mutation of 23S rRNA of H. pylori.

NCT ID: NCT01449500 Not yet recruiting - Dyspepsia Clinical Trials

Supplementation With L. Reuteri in H. Pylori Infected Adults

Start date: October 2011
Phase: N/A
Study type: Interventional

To determine whether simultaneous use of L. reuteri ProGastria and proton pump inhibitors can eradicate H. pylori in humans in the absence of antibiotics.